UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Oral delivery of proteins by biodegradable nanoparticles

Advanced drug delivery reviews, 2013-06, Vol.65 (6), p.811-821

2013

Volltextzugriff (PDF)

Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban

The New England journal of medicine, 2014-11, Vol.371 (22), p.2141-2142

2014

Volltextzugriff (PDF)

Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants

Blood, 2021-01, Vol.137 (1), p.115-125

2021

Volltextzugriff (PDF)

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Thrombosis and haemostasis, 2017-02, Vol.117 (2), p.238-245

2017

Volltextzugriff (PDF)

Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin

Thrombosis research, 2016-10, Vol.146, p.113-118

2016

Volltextzugriff (PDF)

Enhanced cellular uptake and long-term retention of chitosan-modified iron-oxide nanoparticles for MRI-based cell tracking

International journal of nanomedicine, 2012-01, Vol.7 (default), p.4613-4623

2012

Volltextzugriff (PDF)

TNRC9 Downregulates BRCA1 Expression and Promotes Breast Cancer Aggressiveness

Cancer research (Chicago, Ill.), 2013-05, Vol.73 (9), p.2840-2849

2013

Volltextzugriff (PDF)

Direct and cell signaling-based, geometry-induced neuronal differentiation of neural stem cells

Integrative biology (Cambridge), 2011-12, Vol.3 (12), p.127-1214

2011

Volltextzugriff (PDF)

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects

European heart journal, 2022-03, Vol.43 (10), p.985-992

2022

Volltextzugriff (PDF)

Compositional and structural changes in LiNbO3 following deep He+ ion implantation for film exfoliation

Applied physics letters, 2006-09, Vol.89 (11)

2006

Volltextzugriff (PDF)

Reversal of Anticoagulation By Ciraparantag: Time to Onset and Duration of Effect

Blood, 2020-11, Vol.136 (Supplement 1), p.24-24

2020

Volltextzugriff (PDF)

Design of a Randomized, Controlled Study to Evaluate Reversal of Anticoagulation of Ciraparantag in Healthy Adults: Whole Blood Clotting Time Assessed By Automated and Manual Methods

Blood, 2020-11, Vol.136 (Supplement 1), p.20-21

2020

Volltextzugriff (PDF)

Fabrication and material properties of submicrometer SrTiO3 films exfoliated using crystal ion slicing

Applied physics letters, 2007-03, Vol.90 (11)

2007

Volltextzugriff (PDF)

Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-Matched Healthy Volunteers As Measured By Whole Blood Clotting Time

Blood, 2018-11, Vol.132 (Supplement 1), p.987-987

2018

Volltextzugriff (PDF)

A Novel Whole Blood Point-of-Care Coagulometer to Measure the Effect of Direct Oral Anticoagulants and Heparins

Seminars in thrombosis and hemostasis, 2019-04, Vol.45 (3), p.259-263

2019

Volltextzugriff (PDF)

Reversal Agents in Development for the New Oral Anticoagulants

Postgraduate medicine, 2014-11, Vol.126 (7), p.19-24

2014

Volltextzugriff (PDF)

Nonclinical Safety Assessment of PER977: A Small Molecule Reversal Agent for New Oral Anticoagulants and Heparins

International journal of toxicology, 2015-07, Vol.34 (4), p.308-317

2015

Volltextzugriff (PDF)

PER977 REVERSES LOW MOLECULAR WEIGHT HEPARIN IN ADDITION TO IIA AND XA NEW ORAL ANTICOAGULANTS

Journal of the American College of Cardiology, 2015-03, Vol.65 (10), p.A2056-A2056

2015

Volltextzugriff (PDF)

Playing to win

Nature biotechnology, 2009-09, Vol.27 (9), p.793-796

2009

Volltextzugriff (PDF)

Twinning and Dislocation Pileups in Heavily Implanted LiNbO3

Physical review. B, Condensed matter and materials physics, 2011-02, Vol.83 (6)

2011

Volltextzugriff (PDF)

Electro-optically tunable second-harmonic-generation gratings in ion-exfoliated thin films of periodically poled lithium niobate

Applied physics letters, 2007-04, Vol.90 (17)

2007

Volltextzugriff (PDF)

Origin of highly spatially selective etching in deeply implanted complex oxides

Applied physics letters, 2008-11, Vol.93 (18)

2008

Volltextzugriff (PDF)

Playing to win: business plan competitions can earn you more than a plaque for the wall and a pat on the back--they can provide start-up money, experience and the attention your idea needs to get off the ground

Nature biotechnology, 2009-09, Vol.27 (9), p.793

2009

Volltextzugriff (PDF)

Abstract 19361: Reversal of Anticoagulant-induced Bleeding in External and Internal Bleeding Models by PER977, a Small Molecule Anticoagulant Antidote

Circulation (New York, N.Y.), 2014-11, Vol.130 (suppl_2)

2014

Volltextzugriff (PDF)

Studies on C-phycocyanin from Cyanidium caldarium, a eukaryote at the extremes of habitat

Biochimica et biophysica acta, 2000-01, Vol.1456 (2), p.99-107

2000

Volltextzugriff (PDF)

1 – 25 von 50

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(42)
Mit Volltextzugriff
(46)

Publikationsform

Sprache

Englisch
(44)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(16)
Physical Sciences
(14)
Physics
(12)
Physics, Applied
(12)
Humans
(9)
Technology
(8)
Arginine - Analogs & Derivatives
(7)
Materials Science
(7)
Animals
(6)
Administration, Oral
(4)
Adult
(4)
Annealing
(4)
Cardiovascular System & Cardiology
(4)
Female
(4)
Hematology
(4)
Male
(4)
Materials Science, Multidisciplinary
(4)
Physics, Condensed Matter
(4)
Rats
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Oral delivery of proteins by biodegradable nanoparticles

Use of PER977 to Reverse the Anticoagulant Effect of Edoxaban

Ciraparantag, an anticoagulant reversal drug: mechanism of action, pharmacokinetics, and reversal of anticoagulants

Single-dose ciraparantag safely and completely reverses anticoagulant effects of edoxaban

Ciraparantag safely and completely reverses the anticoagulant effects of low molecular weight heparin

Enhanced cellular uptake and long-term retention of chitosan-modified iron-oxide nanoparticles for MRI-based cell tracking

TNRC9 Downregulates BRCA1 Expression and Promotes Breast Cancer Aggressiveness

Direct and cell signaling-based, geometry-induced neuronal differentiation of neural stem cells

Ciraparantag reverses the anticoagulant activity of apixaban and rivaroxaban in healthy elderly subjects

Compositional and structural changes in LiNbO3 following deep He+ ion implantation for film exfoliation

Reversal of Anticoagulation By Ciraparantag: Time to Onset and Duration of Effect

Design of a Randomized, Controlled Study to Evaluate Reversal of Anticoagulation of Ciraparantag in Healthy Adults: Whole Blood Clotting Time Assessed By Automated and Manual Methods

Fabrication and material properties of submicrometer SrTiO3 films exfoliated using crystal ion slicing

Ciraparantag Safely and Effectively Reverses Apixaban and Rivaroxaban in Age-Matched Healthy Volunteers As Measured By Whole Blood Clotting Time

A Novel Whole Blood Point-of-Care Coagulometer to Measure the Effect of Direct Oral Anticoagulants and Heparins

Reversal Agents in Development for the New Oral Anticoagulants

Nonclinical Safety Assessment of PER977: A Small Molecule Reversal Agent for New Oral Anticoagulants and Heparins

PER977 REVERSES LOW MOLECULAR WEIGHT HEPARIN IN ADDITION TO IIA AND XA NEW ORAL ANTICOAGULANTS

Playing to win

Twinning and Dislocation Pileups in Heavily Implanted LiNbO3

Electro-optically tunable second-harmonic-generation gratings in ion-exfoliated thin films of periodically poled lithium niobate

Origin of highly spatially selective etching in deeply implanted complex oxides

Playing to win: business plan competitions can earn you more than a plaque for the wall and a pat on the back--they can provide start-up money, experience and the attention your idea needs to get off the ground

Abstract 19361: Reversal of Anticoagulant-induced Bleeding in External and Internal Bleeding Models by PER977, a Small Molecule Anticoagulant Antidote

Studies on C-phycocyanin from Cyanidium caldarium, a eukaryote at the extremes of habitat

Suchergebnisse filtern